Literature DB >> 10325305

Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority.

Y Manor1, R Handsher, T Halmut, M Neuman, A Bobrov, H Rudich, A Vonsover, L Shulman, O Kew, E Mendelson.   

Abstract

The global eradication of poliomyelitis, believed to be achievable around the year 2000, relies on strategies which include high routine immunization coverage and mass vaccination campaigns, along with continuous monitoring of wild-type virus circulation by using the laboratory-based acute flaccid paralysis (AFP) surveillance. Israel and the Palestinian Authority are located in a geographical region in which poliovirus is still endemic but have been free of poliomyelitis since 1988 as a result of intensive immunization programs and mass vaccination campaigns. To monitor the wild-type virus circulation, environmental surveillance of sewage samples collected monthly from 25 to 30 sites across the country was implemented in 1989 and AFP surveillance began in 1994. The sewage samples were processed in the laboratory with a double-selective tissue culture system, which enabled economical processing of large number of samples. Between 1989 and 1997, 2,294 samples were processed, and wild-type poliovirus was isolated from 17 of them in four clusters, termed "silent outbreaks," in September 1990 (type 3), between May and September 1991 (type 1), between October 1994 and June 1995 (type 1), and in December 1996 (type 1). Fifteen of the 17 positive samples were collected in the Gaza Strip, 1 was collected in the West Bank, and 1 was collected in the Israeli city of Ashdod, located close to the Gaza Strip. The AFP surveillance system failed to detect the circulating wild-type viruses. These findings further emphasize the important role that environmental surveillance can play in monitoring the eradication of polioviruses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325305      PMCID: PMC84919     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Parameters for differentiating vaccine-derived and wild poliovirus strains.

Authors:  J H Nakano; M H Hatch; M L Thieme; B Nottay
Journal:  Prog Med Virol       Date:  1978

2.  Geographic distribution of wild poliovirus type 1 genotypes.

Authors:  R Rico-Hesse; M A Pallansch; B K Nottay; O M Kew
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

3.  Population genetics applied to live poliovirus vaccine.

Authors:  J L MELNICK
Journal:  Am J Public Health Nations Health       Date:  1962-03

4.  BGM, a continuous cell line more sensitive than primary rhesus and African green kidney cells for the recovery of viruses from water.

Authors:  D R Dahling; G Berg; D Berman
Journal:  Health Lab Sci       Date:  1974-10

5.  Strategic viral surveillance of sewage during and following an oral poliovirus vaccine campaign.

Authors:  D B Nelson; R Circo; A S Evans
Journal:  Am J Epidemiol       Date:  1967-11       Impact factor: 4.897

6.  Method for recovering viruses from river water solids.

Authors:  G Berg; D R Dahling
Journal:  Appl Environ Microbiol       Date:  1980-04       Impact factor: 4.792

7.  Natural variation of poliovirus neutralization epitopes.

Authors:  R Crainic; P Couillin; B Blondel; N Cabau; A Boué; F Horodniceanu
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

8.  Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland.

Authors:  T Pöyry; M Stenvik; T Hovi
Journal:  Appl Environ Microbiol       Date:  1988-02       Impact factor: 4.792

9.  Poliomyelitis outbreak in Israel in 1988: a report with two commentaries.

Authors:  P E Slater; W A Orenstein; A Morag; A Avni; R Handsher; M S Green; C Costin; A Yarrow; S Rishpon; O Havkin
Journal:  Lancet       Date:  1990-05-19       Impact factor: 79.321

10.  Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population.

Authors:  T Hovi; K Cantell; A Huovilainen; E Kinnunen; T Kuronen; K Lapinleimu; T Pöyry; M Roivainen; N Salama; M Stenvik
Journal:  Lancet       Date:  1986-06-21       Impact factor: 79.321

View more
  45 in total

1.  Enterovirus surveillance of Italian healthy children.

Authors:  A M Patti; A L Santi; L Fiore; L Vellucci; D De Stefano; E Bellelli; S Barbuti; G M Fara
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece.

Authors:  Evaggelos Dedepsidis; Zaharoula Kyriakopoulou; Vaia Pliaka; Christine Kottaridi; Eugenia Bolanaki; Stamatina Levidiotou-Stefanou; Dimitri Komiotis; Panayotis Markoulatos
Journal:  Appl Environ Microbiol       Date:  2007-09-07       Impact factor: 4.792

3.  Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002.

Authors:  Y Manor; S Blomqvist; D Sofer; J Alfandari; T Halmut; B Abramovitz; E Mendelson; L M Shulman
Journal:  Appl Environ Microbiol       Date:  2007-07-27       Impact factor: 4.792

4.  Molecular identification and full genome analysis of an echovirus 7 strain isolated from the environment in Greece.

Authors:  Zaharoula Kyriakopoulou; Evaggelos Dedepsidis; Vaia Pliaka; Panayotis Mastorakos; Anastassia Stamati; Anastassia Pratti; Stamatina Levidiotou-Stefanou; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2010-01-22       Impact factor: 2.332

5.  Feasibility of quantitative environmental surveillance in poliovirus eradication strategies.

Authors:  W J Lodder; A M Buisman; S A Rutjes; J C Heijne; P F Teunis; A M de Roda Husman
Journal:  Appl Environ Microbiol       Date:  2012-03-23       Impact factor: 4.792

6.  Surveillance of poliomyelitis in Northern Italy: Results of acute flaccid paralysis surveillance and environmental surveillance, 2012-2015.

Authors:  Laura Pellegrinelli; Laura Bubba; Valeria Primache; Elena Pariani; Andrea Battistone; Roberto Delogu; Stefano Fiore; Sandro Binda
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

7.  The Evolutionary Pathway to Virulence of an RNA Virus.

Authors:  Adi Stern; Ming Te Yeh; Tal Zinger; Matt Smith; Caroline Wright; Guy Ling; Rasmus Nielsen; Andrew Macadam; Raul Andino
Journal:  Cell       Date:  2017-03-23       Impact factor: 41.582

8.  The challenge of effective surveillance in moving from low transmission to elimination of schistosomiasis in China.

Authors:  R C Spear; E Y W Seto; E J Carlton; S Liang; J V Remais; B Zhong; D Qiu
Journal:  Int J Parasitol       Date:  2011-09-06       Impact factor: 3.981

9.  Environmental surveillance system to track wild poliovirus transmission.

Authors:  Jagadish M Deshpande; Sushmitha J Shetty; Zaeem A Siddiqui
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

10.  Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.

Authors:  Sabine van der Sanden; Mark A Pallansch; Jan van de Kassteele; Nasr El-Sayed; Roland W Sutter; Marion Koopmans; Harrie van der Avoort
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.